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ABSTRACT 
Objective: An accurate, precise, specific modified High-Performance Liquid Chromatography method was developed for the simultaneous 
quantification of canagliflozin and metformin in bulk and dosage forms.  
Methods: A C18 column (250 x 4.6 mm; 5 µm Phenomenex) was used with mobile phase containing 0.05% v/v triethylamine (pH 6.5): acetonitrile 
(45:55% v/v) at 20 °C and isocratic pump was used for elution. The flow rate was maintained at 1.2 ml/min and eluents were monitored at 215 nm 
which is evaluated by sharp peak. 
Results: The retention times of canagliflozin and metformin were 3.4 min and 12.7 min respectively and showed a good linearity in the concentration 
range of 40-200 µg/ml of Canagliflozin have found a correlation coefficient of 0.999 and 10-50 µg/ml of Metformin with a correlation coefficient of 
0.998. The average percent recoveries were found to be 98.60% and 98.90% respectively for Canagliflozin and Metformin. The developed method 
follows all the validation parameters like accuracy, precision, linearity, limit of detection, limit of quantitation and solution stability.  
Conclusion: The proposed method was found to provide faster retention time with sharp resolution with linearity at a lowest concentration as 
compared to previous methods and this method is validated as per International Conference on Harmonization guidelines and successfully applied 
to the simultaneous estimation of Canagliflozin and metformin in bulk and dosage forms. There was no such novel method for simultaneous 
estimation of Canagliflozin and metformin. Hence the developed method is suitable for industrial analysis of Canagliflozin and metformin with eco-
friendly,green and less expensive solvents 
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INTRODUCTION 
Canagliflozin inhibit SGLT2 by binding more potently (250-times) 
than SGLT1. The 50% inhibitory concentrations (IC50) are 2.2-4.4 
nmol/l and 684-910 nmol/l for SGLT2 and SGLT1 respectively. 
Chemically Canagliflozin is 2S,3R,4R,5S,6R-2-{3-[5-[4-Fluoro-
phenyl)-thiophen-2-ylmethyl]-4-methyl-phenyl}-6-hydroxymethyl-
tetrahydro-pyran-3,4,5-triol. Metformin is an oral antihyperglycemic 
agent that improves glucose tolerance in patients with NIDDM, 
lowering both basal and postprandial plasma glucose [1]. Metformin 
is not chemically or pharmacologically related to any other class of 
oral anti hyperglycemic agents [2]. Chemically it is N, N-
Dimethylimidodicarbonimidicdiamide they are used for 
management of diabetes [3] UPLC method of metformin HCl and 
empagliflozin was reported earlier [4]. Literature survey reveals 
that few methods have been reported on an analysis of canagliflozin 
and metformin individually in pharmaceutical dosage forms. Also, 
the validated HPLC methods reported till date for the simultaneous 
estimation of canagliflozin and metformin does not use mobile phase 
0.05% v/v triethylamine (pH6.5): acetonitrile (45:55% v/v) at 20 °C. 
For elution, the flow rate was maintained at 1.2 ml/min with precise 
retention time and a good linearity in the small concentration range 
of 40-200 µg/ml. Hence, the main objective of the present work was 
to develop a new method for the simultaneous analysis of 
canagliflozin and metformin in bulk and dosage forms [5] by using 
HPLC with more eco-compatible and greener solvents [6][6a].  
MATERIALS AND METHODS 
Reagents and chemicals 
Canagliflozin and metformin were gift samples from Sun Pharma, 
India. Acetonitrile, water and triethylamine were purchased from E. 
Merck, Mumbai, India. All the solvents and reagents used were green 
and HPLC grade. Invokamet contains canagliflozin 50 mg and 
metformin 500 mg tablets manufactured by Janssan 
Pharmaceuticals were locally purchased. 
Equipment 
A Shimadzu Prominence HPLC system provided with DGU-20A3 
degasser was used. The HPLC system consisted of a model LC-20A 
(Prominence) Simadzu, Japan. Data acquisition was carried out 
using LC solutions software. The chromatographic analysis was 
performed on Phenomenex C-18 column (250 × 4.6 mm; 5 µm). 
Chromatographic conditions 
Mobile phase consisting of 0.05% v/v triethylamine of pH 6.5 
(orthophosphoric acid used to maintain the pH): acetonitrile (45:55% 
v/v). The mobile phase was filtered through Millipore nylon disc filter 
of 0.45 µm followed by ultrasonication for 3 min. The flow rate was 
maintained at 1.2 ml/min with an injection volume of 20 µl. Eluents 
were monitored at 215 nm and the separation was found. 
Preparation of stock and standard solutions 
The stock solutions of canagliflozin and metformin of concentration 
1 mg/ml were prepared in 10 ml volumetric flask using methanol as 
a solvent. The working standard solutions in the concentration 
ranging from 40-200 µg/ml of canagliflozin and 10-50 µg/ml of 
metformin were prepared by appropriately diluting the stock 
solutions with acetonitrile as diluents and kept at 20 °C. 
Method validation 
The method was validated according to the ICH guidelines [10]. 
Specificity 
Canagliflozin and Metformin in pure form were evaluated by 
comparing the standard and sample solutions with a blank. 
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Specificity is a measure of the degree of interference in the analysis 
of the sample mixtures into which known impurities were added. 
Specificity of the method was carried out by comparing 
chromatogram to check interference peaks. 
Linearity 
The aliquots of five different concentrations were evaluated across 
the range of the analytical procedure. A series of standard dilutions 
of canagliflozin and metformin were prepared over a concentration 
range of 40-200µg/ml (40, 80, 120, 160 and 200µg/ml) and 10-
50µg/ml (10, 20, 30, 40 and 50µg/ml) respectively from stock 
solutions. Peak area was determined with correspondence to the 
analyte concentration and the test results were evaluated by 
appropriate statistical methods where by slope, intercept and 
regression (R2) and correlation coefficients (r2) were calculated. 
Precision 
Precision was measured in the same analytical condition in terms of 
repeatability of procedure, application and measurement. 
Repeatability of the standard application was carried out using six 
replicates of the standard concentration of canaglilozin (80µg/ml) 
and metformin (20µg/ml). Peak area is indicated less than 2% RSD 
which indicates the precision of the method. 
Accuracy 
The accuracy of this method was found in the whole analytical 
procedure. Accuracy (recovery) of the method was tested by spiking 
80, 100 and 120% of canagliflozin (80µg/ml) and metformin 
(20µg/ml) standard concentrations. These solutions were analyzed 
by a developed method in triplicate. The calculation of %RSD and % 
recovery was done throughout the addition level. 
Robustness 
In this method by changing the flow rate and wave length the result 
withstand rigorous testing. The HPLC parameters like capacity 
factor, tailing factor, theoretical plate number and % assay were 
observed. The flow rate of the mobile phase was maintained at 1.2 
ml/min. To prove the robustness of this method, the flow rate was 
changed by±20% and wavelength by±5 nm. 
Limit of detection and quantification  
Calibration curve method was used to determine LOD and LOQ. 
Standard solutions of canagliflozin and metformin were prepared in the 
range of 40-200µg/ml and 10-50µg/ml injected (20 µl) in triplicate. The 
average peak area of two drugs was plotted against concentration. LOD 
and LOQ were calculated by using following equations:  
LOD = (3.3 ×σ)/m; LOQ= (10.0×σ)/m 
System suitability 
System suitability was carried out by injecting a standard 
concentration (40µg/ml of canagliflozin and 10µg/ml of metformin) 
at different injection volumes in the range of 10-50 µl and % RSD 
was calculated. 
Assay 
Of the combined dosage forms presently available in the market, 
canagliflozin (containing 50 mg) and metformin (containing 500 
mg) were used in these studies. Powder blend (10 tablets of each 
brand) equivalent to 10 mg of Canagliflozin and Metformin were 
separately weighed and transferred to a 10 ml volumetric flask. 5 ml 
of methanol was added followed by sonication for 5 min and volume 
was made up to the mark with methanol. The solutions were 
centrifuged and the supernatant were filtered using syringe filter 
(13 mm, 0.45 µm). Aliquots of the drugs of concentration 80µg/ml 
and 20µg/ml of Canagliflozin and Metformin were prepared and 
analyzed in triplicates. The amount present in each tablet was 
calculated by comparing the areas of standard Canagliflozin and 
Metformin with that of the sample. 
RESULTS AND DISCUSSION 
Validation of the chromatographic conditions 
The present work was carried out with a view for development of 
ecofriendly green HPLC method for the simultaneous estimation of 
canagliflozin and metformin in bulk and dosage forms. Initial trials 
were carried out with Phenomenex C-18 column (250 x 4.6 mm; 5 
µm) using mobile phase 0.05% v/v formic acid and methanol 
(60:40% v/v) at a flow rate of 1.2 ml/min and acetonitrile as the 
diluents. The quantification was carried out at 215 nm. Under these 
conditions, canagliflozin was eluted at 3.16 min and metformin at 
4.88 min. The canagliflozin was almost eluted with the solvent front. 
In the other modification trial, methanol was replaced with 
acetonitrile and mobile phase combination of 80:20 % v/v was used 
and kept at 20 °C. At a flow rate of 1.2 ml/min the elution time for 
canagliflozin was 3.61 min and metformin was 6.70 min. However, 
the resolution between the solvent front and the canagliflozin peak 
was not prominent. Then, 0.05% v/v triethylamine was taken 
(adjusted to pH 6.5 with orthophosphoric acid) with acetonitrile in 
the ratio of 50:50 % v/v and the flow rate was 1.2 ml/min. Under 
these conditions, the canagliflozin was eluted at 5.14 min and 
Metformin at a longer retention of 20.23 min. Finally, the ratio of the 
mobile phase changed to 45:55% v/v of 0.05% v/v triethylamine and 
acetonitrile. The flow rate of 1.2 ml/min is maintained in order to 
achieve a proper resolution of both canagliflozin and metformin peaks 
respectively. Under these conditions, the canagliflozin and metformin 
peaks were eluted at 3.47 min and 12.34 min respectively. 
Symmetrical peaks were found and the tailing factor was within the 
limits. For quantitative analytical purpose wavelength was set at 215 
nm, which provided better reproducibility without interference. The 
peak purity was found to be greater than 0.9999 for both the drugs, 
canagliflozin and metformin used in the analysis. A sample 
chromatogram of canagliflozin and metformin were given in fig. 1 
along with UV spectra. 
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Fig. 1: Standard chromatogram of canagliflozin (40μg/ml) and metformin (20μg/ml) mixture (A); and (B) overlay UV spectra of 
canagliflozin and metformin 
 
Method validation  
Specificity 
The specificity of this modified eco-friendly green method was 
established by using solutions of diluents, placebo, standard and test 
sample (Tablets). The inference from the 3D plots of placebo and 
test samples, shown in fig. 2, proves that there were no co-eluting 
peaks at the retention time of canagliflozin and metformin. The 
results showed that peak of drug candidate was pure and the 
excipients in the formulation did not interfere with the analysis. The 
purity of peak for sample and standard were found to be greater 
than 0.9999, hence the method confirms specificity. 
 
 
Fig. 2: Overlaid canagliflozin (40-200μg/ml) and metformin (10-50μg/ml) standard chromatograms 
 
Linearity 
A linear relationship evaluated across a concentration range 40-
200µg/ml of canagliflozin and 10-50µg/ml of metformin in 
triplicates (n = 3). The concentration range was selected based on 
80, 100 and 120% of the test concentration for assay.  
Peak area and concentration data were subjected to least square 
regression analysis. The correlation coefficients (R) were found to 
be 0.999 and 0.998 respectively for canagliflozin and metformin and 
indicate a good linearity within the concentration range selected. 
The data of the calibration curve was given in table 1 and 
chromatograms were shown in fig 2. 
Precision 
Precision studies were carried out in terms of repeatability. 
Repeatability of standard application was assessed by using six 
replicates of concentration at 80µg/ml of canagliflozin and 20µg/ml 
of metformin and the data was given in Table-2. The % RSD was 
found to be less than 2 for peak areas; this shows the closeness of 
the data values to each other, indicating the method was précised. 
Accuracy 
Accuracy of the proposed method was ascertained by performing 
recovery studies using the standard addition method by spiking the 
known quantities of standards at 80, 100, and 120 % to the test 
solution of 80µg/ml of canagliflozin and 20µg/ml of metformin. The 
analyte peak is evaluated by 3D plots of the chromatogram in order 
to confirm the existence of components at 3.4 min and 12.7 min 
elution time of canagliflozin and metformin respectively and shown 
in fig. 3. The recoveries were found to be 99.15-101.73%, 99.04-
100.04%, and 98.24-99.50% at 80, 100 and 120% respectively for 
canagliflozin and metformin. These results indicate a good accuracy 
of the method to that of the labelled claim. The obtained recovery 
results were given in table 1.  
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Table 1: Linearity, accuracy and precision data 
Validation parameters  Parameters Canagliflozin Metformin 
Linearity (n=3) Range 40-200 µg/ml 10-50µg/ml 
Regression equation Y=11632x-1152 Y=53152x-7026 
Regression coefficient(R2) 0.999 0.998 
Correlation coefficient(r2) 0.998 0.997 
Accuracy(n=3) % Level of addition Mean%±recovery(RSD) Mean%±recovery(RSD) 
80 99.59±(1.95) 100.03±(1.08) 
100 99.12±(0.89) 101.07±(1.02) 
120 99.82±(0.64) 100.09±(0.86) 
Precision (n=6)  
System precision Average peak area of the standard sample (RSD) 839193±(1.94) 9404±(1.13) 
Method precision Average peak area of the Assay sample (RSD) 855010±(0.81) 8891±(0.16) 
For Linearity and Accuracy n = 3 Mean %±recovery (RSD) and for Precision n=6 Mean %±recovery (RSD) 
 
Robustness 
As part of the robustness, a deliberate change in the flow rate and 
wavelength was made to evaluate the impact on the method. 
Significant change in retention time was found with flow rate and 
showed no change with wavelength. Moreover % assay values were 
within limits and these results indicated minor changes in the flow 
rate but wavelength didn’t affected the assay results. The results 
were given in table 2. 
 
 
 
 
Fig. 3: 3D plots of sample standard and diluents 
 
Detection and quantification limits 
LOD and LOQ were calculated from the average slope and standard 
deviation from the calibration curve. LOD for canagliflozin and 
metformin was found to be 0.326 and 0.436 mg/ml respectively. 
LOQ for canagliflozin and metformin was found to be 0.990 and 
1.321 mg/ml respectively. 
System suitability 
System suitability studies were carried out by injecting a 40 mg/ml 
standard of canagliflozin and 10 μg/ml of metformin respectively at 
injection volumes ranging from 10-50 μL. With increment of 
injection volumes, the % RSD for tailing factor and theoretical plate 
number were calculated and were found to be within limits. 
Assay 
Assay of canagliflozin and metformin in tablets was performed by 
the proposed method and the % assay was calculated as an average 
of 3 determinations. These results indicate that the present HPLC 
method is quite eco friendly using green solvents successfully for the 
simultaneous assay of canagliflozin and metformin respectively in 
bulk and dosage forms. The assay values were found to be within the 
limits and the data was given in table 4. 
 
Table 2: Robustness data for wavelength 
Drug Parameter range Retention time in min. Theoretical plates (N) Tailing factor Capacity factor (k) % assay 
Canagliflozin 210 
215 
220 
3.5 
3.54 
3.5 
5274.5 
6079.5 
5317.1 
1.0 
1.0 
1.3 
1.1 
0.8 
0.8 
98.5 
100.2 
100.3 
Metformin 210 
215 
220 
12.7 
12.7 
12.7 
14152.6 
14886.4 
14086.0 
1.4 
1.3 
1.3 
5.6 
5.6 
5.6 
101.2 
100.3 
99.15 
n=3 
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Table 3: Robustness data for flow rate 
Drug Parameter range Retention time in min Theoretical plates (N) Tailing factor Capacity factor (k) % assay 
Canagliflozin 1.0 
1.2 
1.4 
4.5 
3.7 
3.4 
5282.3 
4895.4 
4906.2 
1.42 
1.37 
1.39 
0.99 
0.94 
1.1 
98.6 
101.2 
99.8 
Metformin 1.0 
1.2 
1.4 
13.8 
12.7 
11 
13827.6 
13040.7 
13633.8 
1.47 
1.39 
1.38 
5.54 
5.62 
5.79 
101.8 
100.2 
98.2 
n = 3 
 
Table 4: Assay of formulation 
Formulation Drug Labled claim in mg Amount found mean±SD % assay % RSD 
Invokamet Canagliflozin 50 mg 47.69±0.11 98.2 1.19 
Metformin 500 mg 498.51±0.34 99.8 1.2 
mean±SD and mean±% RSD 
 
Stability of the stock solution 
The stability of the stock solution was determined by analyzing 
the samples under refrigeration (8±1 °C) at different time 
intervals up to 48 h. The % variation in assay values at different 
time intervals were found 0.825 for canagliflozin and 0.546 for 
metformin from the initial zero time interval solution, thus 
indicating that the solutions were stable for a period of 48 h 
when stored at 8±1 °C. 
DISCUSSION 
The retention times of canagliflozin and metformin were 3.4 min 
and 12.7 min respectively. The correlation coefficient of 
Canagliflozin was found to be 0.999 and Metformin 0.998. In 
comparison to other published methods, this environmental friendly 
method shows linearity in low concentration range of 40-200 µg/ml 
and 10-50 µg/ml of canagliflozin and metformin respectively [8]. 
The average percentage recoveries were found to be 98.60% and 
98.90% respectively for canagliflozin and metformin which is better 
than the earlier publications. The eco-compatible developed method 
follows all the validation parameters like accuracy, precision, 
linearity, limit of detection, limit of quantitation and solution 
stability when compared to other established works [9]. 
CONCLUSION 
The proposed HPLC method provides increased sensitivity when 
compared to other published HPLC methods. It is validated as per 
International Conference on Harmonization (ICH) Guidelines and 
can be used as quality control analysis for the simultaneous 
estimation of canagliflozin and metformin using isocratic mode of 
elution. The results of linearity, precision, accuracy and specificity 
proved to be within the limits. The method provides selective and 
simultaneous quantification of canagliflozin and metformin without 
interferences from diluents and placebo. Overall, the proposed 
method is highly sensitive, reproducible, reliable, rapid specific and 
eco-friendly employed in quality control for simultaneous 
estimation of canagliflozin and metformin in bulk and in dosage 
forms that will be available in near future in the market. 
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